Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prophylactic Tranexamic Acid for Postpartum Hemorrhage in Autoimmune Disease
NCT06754371Phase 4Recruiting
- Sponsor
- Renji Hospital
- Start
- Jan 2025
- Primary completion
- Jan 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tranexamic acid in postpartum hemorrhage (PPH), sponsored by Renji Hospital. Started Jan 2025; status: recruiting.
02
Drugs
tranexamic acid
03
Conditions
postpartum hemorrhage (PPH)
Beyond the preview
Go deeper on NCT06754371.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06754371.